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Abstract
Background: TRPV4 and the cellular cytoskeleton have each been reported to influence cellular mechanosensitive
processes as well as the development of mechanical hyperalgesia. If and how TRPV4 interacts with the microtubule and
actin cytoskeleton at a molecular and functional level is not known.
Methodology and Principal Findings: We investigated the interaction of TRPV4 with cytoskeletal components
biochemically, cell biologically by observing morphological changes of DRG-neurons and DRG-neuron-derived F-11 cells,
as well as functionally with calcium imaging. We find that TRPV4 physically interacts with tubulin, actin and neurofilament
proteins as well as the nociceptive molecules PKCe and CamKII. The C-terminus of TRPV4 is sufficient for the direct
interaction with tubulin and actin, both with their soluble and their polymeric forms. Actin and tubulin compete for binding.
The interaction with TRPV4 stabilizes microtubules even under depolymerizing conditions in vitro. Accordingly, in cellular
systems TRPV4 colocalizes with actin and microtubules enriched structures at submembranous regions. Both expression
and activation of TRPV4 induces striking morphological changes affecting lamellipodial, filopodial, growth cone, and neurite
structures in non-neuronal cells, in DRG-neuron derived F11 cells, and also in IB4-positive DRG neurons. The functional
interaction of TRPV4 and the cytoskeleton is mutual as Taxol, a microtubule stabilizer, reduces the Ca
2+-influx via TRPV4.
Conclusions and Significance: TRPV4 acts as a regulator for both, the microtubule and the actin. In turn, we describe that
microtubule dynamics are an important regulator of TRPV4 activity. TRPV4 forms a supra-molecular complex containing
cytoskeletal proteins and regulatory kinases. Thereby it can integrate signaling of various intracellular second messengers
and signaling cascades, as well as cytoskeletal dynamics. This study points out the existence of cross-talks between non-
selective cation channels and cytoskeleton at multiple levels. These cross talks may help us to understand the molecular
basis of the Taxol-induced neuropathic pain development commonly observed in cancer patients.
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Introduction
Transient receptor potential vanilloid sub type 4 (TRPV4) is a
member of TRP super family of Ca
2+-permeable non-selective
cation channels. This polymodal receptor is involved in cellular
processes such as mechanosensation, osmosensation and thermo-
sensation [1–5]. Some of these sensory functions are well conserved
in different species. For example, mammalian TRPV4 can rescue
mechanosensitive defects observed in C.elegans OSM-9 mutants [5].
In higher organisms TRPV4 is endogenously expressed in
nociceptive dorsal root ganglion (DRG) neurons but also in many
non-neuronal tissues and cells such as skin, kidney corneal epithelial
cells [6], cerebral microvascular endothelial cells [7], cortical
astrocytes [8], tracheal epithelial cells [9], keratinocyte cell lines[10]
and in other cells. The widespread distribution of TRPV4 is
indicative of its involvement in various physiological functions.
Indeed, TRPV4 is of importance in shear stress-induced vasodila-
tion [11] as well as in auditory functions [12–13]. Recently TRPV4
gained importance as it has been linked with the development of
different pathophysiological conditions such as neuropathic pain,
cystic fibrosis, brachyolmia and cancer [14–18].
From several reports, the involvement of cytoskeleton can be
correlated with the localization and function of TRPV4. For
example, TRPV4 is found in structures like cilia in various tissues
and cells [9,19–21] and in lamellipodia, where it regulates the
dynamics of cytoskeleton [22–23]. Many cellular functions
involving TRPV4 are known to require active participation of
the cytoskeleton. For example, TRPV4 activity is central to
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cells [6,10,24], a process where actin-binding proteins contribute
to cell volume regulatory ion channel activation [24–26]. In
addition, TRPV4 has a conserved role in mechanotransduction, a
complex process that involves both actin and microtubule
cytoskeletal components [27–29]. The interplay of TRPV4 with
microtubule cytoskeleton also appears on a behavioural level,
where alteration of microtubule dynamics by Taxol induces a
TRPV4-dependent painful peripheral neuropathy [30]. While all
these cellular and behavioural studies strongly suggest that TRPV4
shares a functional relation with the cytoskeleton, so far a direct
link of TRPV4 with the cytoskeleton has not been demonstrated.
Thus, a molecular mechanism for the role of TRPV4 and the
cytoskeleton in pain, mechanosensation as well as other cellular
functions remains elusive.
Recently, we have established a functional interplay between
TRPV1, a close homologue of TRPV4, and the microtubule
cytoskeleton [31–35]. We demonstrated the physical interaction of
microtubule cytoskeleton with TRPV1 via two novel tubulin-
binding motifs [36–37]. Based on our previous experiments done
on TRPV1 and the sequence homology between TRPV1 and
TRPV4, we predicted that TRPV4 might interact with tubulin via
its C-terminal domain. Therefore, in this work we set out to
explore if TRPV4 physically and functionally interacts with actin
and microtubule cytoskeletal components.
Results
TRPV4 interacts with endogenous actin and tubulin
In order to test if TRPV4 interacts with cytoskeletal proteins like
tubulin and actin, we performed co-immunoprecipitation experi-
ments with affinity purified TRPV4 antibodies. CHO-KI-TRPV4
stable cell lines were used, which express low levels of TRPV4. In
immunoblot analysis, we observed that TRPV4 antibodies
precipitated TRPV4 together with actin and tubulin proteins
(Fig. 1a). Presence of tubulin and actin was not observed when a
similar co-immunoprecipitation was performed from the same cell
extract using an antibody, which was not raised against TRPV4. To
confirm further that the tubulin interaction is occurring even in
endogenous tissues, we isolate DRG neurons from rat and
performed similar co-immunoprecipitation experiments with affin-
ity purified TRPV4 antibodies. We observed that tubulin co-
immunoprecipitated with TRPV4 even from DRG neurons (1b).
The C-terminus of TRPV4 is sufficient for interaction with
actin and tubulin
To identify, which part of the TRPV4 interacts with actin and/
or tubulin proteins, we performed a pull down experiment using
maltose-binding-protein (MBP)-fused to the N- and C-termini of
TRPV4. According to our prediction [37], at least one tubulin-
binding site is located within the C-terminus of TRPV4 (Fig. S1)
Figure 1. Interaction of soluble tubulin and actin with TRPV4. a. Co-immunoprecipitation of actin and tubulin with TRPV4. Cell extracts from
CHO-KI cells stably expressing TRPV4 (lane 1) was immunoprecipitated by TRPV4 antibody (lane 2) or by a non-specific antibody (lane 3). Blots were
probed for TRPV4 (left side), tubulin (middle) and actin (right side). b. Co-immunoprecipitation of tubulin with TRPV4. Extracts from DRG (lane 1) was
immunoprecipitated by TRPV4 antibody (lane 2) or by a non-specific antibody (lane 3). Blots were probed for TRPV4 (upper panel) and tubulin (lower
side). c. MBP-TRPV4-Ct (lane 2-3) but not MBP-LacZ (lane 4–5) forms specific complexes when incubated with mammalian brain extract (lane 1), both
in presence (lane 2 and 4) or absence (lane 3 and 5) of Ca
2+ (1 mM). Presence of PKCe, actin and tubulin are observed only in lane 2 and 3.
Neurofilament in the pull down samples is visible only after exposing for a prolonged time. Presence of CamKII is noted only in the presence of Ca
2+
(lane 2). Note that the amount of MBP-LacZ used, as a negative control for the pull down experiment is much more than MBP-TRPV4-Ct. d. Tubulin
interacts with TRPV4-Ct directly. MBP-LacZ (lane 1–2) or MBP-TRPV4-Ct (lane 3–4) was incubated with buffer only (lane 1 and 3) or with purified
tubulin (lane 2 and 4). Pulled down samples were probed for different isotype-specific and different post-translationally modified tubulins. e. Actin
interacts directly with TRPV4-Ct. MBP-TRPV4-Ct (lane 1–2) or MBP-LacZ (lane 3–4) was incubated with purified actin (lane 1–4) either in the presence
(lane 1-and 3) or absence (lane 2 and 4) of Ca
2+ (1 mM) and subsequently probed for bound actin. f. Soluble tubulin and actin competes for the C-
terminal cytoplasmic fragment of TRPV4. MBP-TRPV4-Ct was incubated with only tubulin (lane 1), with only actin (lane 2), or both tubulin and actin in
a sequential manner (lane 3–4). Prior incubation of tubulin inhibits further binding of actin (lane 3). Similarly, prior incubation of actin significantly
reduces the further binding of tubulin (lane 4).
doi:10.1371/journal.pone.0011654.g001
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remained poor, we restricted our study to the C-terminus of
TRPV4 only. Pull down was performed from adult porcine brain
homogenate as well as from F11 cell lysate, a fusion-cell of rat
DRG neurons and mouse neuroblastoma cells [38]. In immuno-
blot analysis, we observed MBP-TRPV4-C-terminus fusion
protein (MBP-TRPV4-Ct) but not the control fusion protein
MBP-LacZ to pull down soluble tubulin and actin (Fig. 1c, S2).
When probed for the presence of another cytoskeletal element,
namely soluble neurofilament proteins, only minimal amounts of
NF116 kDa and no NF200 kDa were detected.
As activation of TRPV4 results in high Ca
2+-influx, we tested if
higher concentration of Ca
2+ could modulate these interactions.
However, we observed that tubulin and actin interaction with
TRPV4 do not depend on Ca
2+ (Fig. 1c, S2).
TRPV4-Ct forms a Ca
2+-sensitive supra-molecular
signaling complex made of actin, tubulin as well as
nociceptive signaling components PKCe and CamKII
Previously we have demonstrated that mechanical hyperalgesia
induced agonists of novel estrogen receptor GPR30 strongly
correlates with the translocation of PKCe in IB4 (+) neurons [39].
Moreover, mechanical hyperalgesia can be induced by activation of
the epsilon isoform of PKC (PKCe), a well-described pro-
nociceptive signaling molecule [39–43]. In addition, calmodulin,
and CamKII function has been linked with the chronic inflamma-
tory pain [44–46]. Thus, we tested if the TRPV4-actin/tubulin
complex also contains PKCe and/or CamKII. We found CamKII
to be present in the eluates of the pull-down material both from
soluble brain and F11 cell extract, but only in the presence of Ca
2+
(Fig. 1c, Fig. S1). In addition, we also detected PKCe in the MBP-
TRPV4-Ct complex, both in presence and absence of Ca
2+.
Presence of PKCe or CamKII was not observed with the control
protein MBP-LacZ. Thus, using two different biological sources,
our results indicate that TRPV4-Ct can form supra-molecular
complexes consisting of structural and signaling proteins.
MBP-TRPV4-Ct interacts directly with soluble tubulin and
actin
To test if TRPV4-Ct interacts directly with tubulin and actin, we
performed pull down experiments with the purified MBP-TRPV4-
Ct, tubulin, and actin. As expected, MBP-TRPV4-Ct but not MBP-
LacZ pulls down tubulin (Fig. 1d). Tubulin is subjected to different
types of post-translational modification, which regulate the process
of microtubule stabilization, destabilization and maturation. Thus,
we tested for the presence of various post-translationally modified
tubulins in the complex formed with MBP-TRPV4-Ct. Indeed we
found a large number of these post-translationally modified tubulins
and neuron-specific b-III tubulin (Fig. 1d).
Next we tested if also soluble actin interacts directly with MBP-
TRPV4-Ct. In immunoblot analysis, we observed that the MBP-
TRPV4-Ct pulls down purified actin, while under the same
conditions MBP-LacZ was unable to pull down any actin (Fig. 1e).
Again, we observed no influence of Ca
2+ on this interaction.
Tubulin and actin compete for binding to MBP-TRPV4-Ct
To understand if tubulin binding affects actin binding and vice
versa, we performed a competition experiment between soluble
tubulin and soluble actin for the binding to MBP-TRPV4-Ct. Soluble
tubulin and actin were added to MBP-TRPV4-Ct sequentially before
being analysed for their binding to TRPV4 (Fig. 1f). As control either
soluble tubulin or soluble actin were used alone and washed in the
same manner. We observed that the amount of bound tubulin was
strongly reduced if MBP-TRPV4-Ct was initially incubated with actin
( F i g .1 f ) .I n v e r s e l y ,t h ea m o u n to fb o u n da c t i ni sv e r yl o wi fM B P -
TRPV4-Ct is initially incubated with tubulin. These results indicate
that both actin and tubulin compete for binding to MBP-TRPV4-Ct.
MBP-TRPV4-Ct interacts with polymerized actin and
tubulin filaments and favours formation of stable
microtubules
Next we addressed whether TRPV4canalso bind to polymerized
filaments. We observed that MBP-TRPV4-Ct co-sedimented with
polymerized actin and thus appeared in the pellet fraction (Fig. 2a).
Under the same conditions, MBP only showed no interaction with
polymerized actin filaments.
Here we probed if the MBP-TRPV4-Ct can also interact with
polymerized microtubules. We observed that MBP-TRPV4-Ct but
not MBP alone co-sedimented with Taxol-stabilized polymerized
microtubules (Fig. 2b, left side). In addition, we observed that if
MBP-TRPV4-Ct was added to saturated tubulin dimer solution
during GTP-induced microtubule formation, co-sedimentation of
MBP-TRPV4-Ct with polymerized microtubules was also observed
(Fig. 2b, right side). Again, only MBP, the control protein failed to
bind polymerized microtubules. These results confirm that MBP-
TRPV4-Ct directly interacts with filamentous microtubules.
We tested if MBP-TRPV4-Ct can change the physico-chemical
properties of the microtubules. For that purpose, we analysed the
stability of the microtubules by comparing the amount of
microtubules formed under depolymerization conditions, both in
the presence or absence of MBP-TRPV4-Ct. We observed that the
presence of MBP-TRPV4-Ct favours microtubule formation even
in presence of Nocodazole, Ca
2+, or both (Fig. 2c). In contrast, in
absence of MBP-TRPV4-Ct much lower amount of microtubules
was formed. MBP as a control protein does not interact with the
polymerised microtubules and thus fails to provide stability to the
microtubules. This result suggests a stabilization effect of MBP-
TRPV4-Ct on microtubules.
TRPV4 localizes to actin- and microtubule-enriched
regions in F11 cell
Based on a RT-PCR analysis demonstrating the amplification of
small mRNA fragment, endogenous expression of TRPV4 in F11
cell has been proposed [47]. However, by immunofluorescence
analysis two different polyclonal antibodies which recognise the C-
terminal region of TRPV4, we could not observe any specific
endogenous expression of TRPV4 in F11 cells. To investigate if
the biochemical interaction under in vitro conditions also occurs in
vivo, we expressed TRPV4 in F11 cells as well as in other non-
neuronal cells and performed co-localization experiments. The
purpose of TRPV4 overexpression in F-11 cells is to mimic the
physiological situation in DRG neurons.
Using fluorescent labelled Phalloidin, we observed co-localiza-
tion of TRPV4 with actin at various actin cytoskeleton enriched
regions, such as the actin ribs of the cortical membranous regions,
and at filopodial and lamellipodial structures (Fig. S3).
As some of these structures are very dynamic and sensitive to
environmental changes such as temperature drops or media
composition, we attempted to confirm that the observed co-localization
in these structures was not a fixation artefact. Thus, we performed live
cell imaging by expressing TRPV4 - G F Pa n dR F P - a c t i ni nF 1 1c e l l s
and we observed co-localization at filopodia, at lamellipodia, and also
at cortical actin-rich structures (Fig. 3a-c). We also noted co-localization
at actin-rich structures, which resemble focal adhesion points (Fig. 3b).
This is in agreement with the fact that focal adhesion points are
important for cellular mechanosensory functions [48].
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microtubules. We observed co-localization between TRPV4 and
microtubules in fixed F11 cells all along neurite-like structures. Co-
localization was observed at the plasma membrane and at
membrane ruffles that are enriched in TRPV4 (Fig. 3d-e). In
addition, we noted the presence of numerous microtubule ends at
the submembranous regions. Often these microtubule ends
extended to the plasma membrane and seemed to be stabilized at
the membranous regions containing TRPV4. Co-localization of
tubulin and TRPV4 was also observed in filopodial structures that
were developed from growth cones, from neurite-like structures as
well as from cell bodies. This kind of submembranous tubulin
accumulation was not observed in non-transfected cells (Fig. 3f),
implying that this effect is primarily due to the presence of TRPV4.
Activation of TRPV4 results in fast retraction of growth
cones in F11 cell
TRPV4 localizes to growth cones when expressed in F11 cells.
So we tested if TRPV4 activation can alter the morphology and
movement of growth cones. For that purpose we expressed
TRPV4-GFP along with RFP-actin and performed live cell
imaging. We observed that in response to 4a-phorbol-didecanoate
(4aPDD, 1 mM), a TRPV4-specific agonist [22], neurites from
TRPV4-GFP expressing F11 cells show rapid change in its
morphology and induce multiple varicosities (Fig. S4). In response
to 4aPDD, TRPV4-GFP containing growth cones retract quickly
(Fig. 4a). Under the same conditions growth cones developing
from non-transfected cells do not show any retraction, thus
assuring specificity of the pharmacological treatment. These results
strongly suggest that TRPV4 can regulate the growth cone
motility.
Long-term exposure to a TRPV4 agonist restricts neurite
outgrowth in a subset of primary DRG neurons
To validate the effect of TRPV4 activation on growth cones in a
system with endogenous TRPV4 expression, we used primary
neurons and tested the effect of TRPV4 activation. DRG neurons
from adult male rat were cultured for 5 days and treated with
4aPDD (1 mM) for short-term (20 minutes). Live cell-imaging
revealed indications of slow retraction of neurites in response to
Figure 2. TRPV4 interacts directly with polymerized actin and microtubule filaments. MBP and MBP-TRPV4-Ct were centrifuged at
70000 g/30 min/4uC and only soluble proteins present in the supernatant were used for all co-sedimentation experiments. a. MBP-TRPV4-Ct co-
sediments with polymerized actin filaments. Actin was polymerized either in presence of MBP-TRPV4-Ct (lane 1 and 4), in presence of MBP only (lane
2 and 5) or in buffer only (lane 3 and 6). Polymerized actin filaments and associated proteins were isolated from remaining soluble actin and unbound
proteins by centrifugal separation of pellets (P, lane 1–3) from corresponding supernatants (S, lane 4–6). The entire amount of MBP remains in the
supernatant (lane 5) while a significant amount of MBP-TRPV4-Ct appears in the pellet (lane 1). Arrows indicate the position of respective proteins. b.
MBP-TRPV4-Ct co-sediments with microtubules. Taxol-stabilized microtubules (left panel) were incubated with MBP (lane 1–2), MBP-TRPV4-Ct (lane 3–
4) or with buffer only (lane 5–6) followed by the centrifugal separation of pellet (P) consisting MT and bound proteins from supernatant (S) consisting
of soluble tubulin and other unbound proteins (left side panel). In right side panel, soluble tubulin and GTP was incubated with MBP (lane 1–2), MBP-
TRPV4-Ct (lane 3–4) or buffer only (lane 5–6) followed by separation of pellet (P) and supernatant (S). Note the specific presence of MBP-TRPV4-Ct in
the pellet in both cases (in lane 4). c. MBP-TRPV4-Ct stabilizes microtubules against depolymerizing factors. Microtubules was formed form soluble
tubulin in buffer (lane 1), along with MBP (lane 2) or along with MBP-TRPV4-Ct (lane 3) in control condition (left most panel), in presence of
Nocodazole (middle left panel), in presence of Ca
2+ (middle right side) or in presence of both Nocodazole and Ca
2+ (right most). Microtubules and
bound proteins present in the pellet fraction (P) were isolated from unpolymerized tubulin and unbound proteins remaining in the supernatant (S)
by centrifugal separation. Note the enhancement of polymerized microtubules (represented by tubulin present in lane 3, P fraction in every
conditions) due to the presence of MBP-TRPV4-Ct.
doi:10.1371/journal.pone.0011654.g002
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PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11654Figure 3. TRPV4 co-localizes with actin and microtubule cytoskeleton. a–c. Shown are the live-cell confocal images of F11 cells expressing
TRV4-GFP (green) and RFP-actin (red). Presences of TRPV4-GFP specifically in actin-enriched structures are shown. a. Enlarged view of lamellipodia
and at the tip of the actin filaments are shown. b–c. Enlarged view of focal adhesion point-like structures (b) and cell cortex with actin ribs (c) are
shown. Arrows indicate the localization of TRPV4-GFP at filopodial tips. d–f. TRPV4 co-localizes with microtubule cytoskeleton. Shown are the
confocal images of F11 cells immunostained for TRPV4 (green) and tyrosinated tubulin (red). Arrows indicate presence and acumulation of
microtubules in thin filopodial structures (d, upper panel) and thin lamellipodial structures (e, middle panel). The status of the microtubules in the
non-transfected cells are shown in below (f, lower panel).
doi:10.1371/journal.pone.0011654.g003
TRPV4 Regulates Cytoskeleton
PLoS ONE | www.plosone.org 5 July 2010 | Volume 5 | Issue 7 | e11654Figure 4. TRPV4 localizes in the growth cone and regulates axonal motility as activation of TRPV4 results in microtubule
disassembly. a. Shown are the confocal time series images of live F11 cell expressing TRPV4-GFP (green) and RFP-Actin (red). Fluorescence images
were superimposed on the DIC images. Addition of 4aPDD (1 mM) results in growth cone retraction of the transfected cell (T) but not from the non-
transfected (NT) cells. b. Prolonged activation of endogenous TRPV4 reduces neurite outgrowth. Shown are the images of cultured DRG neurons
stained for IB4 (red) and bIII tubulin (green). IB4-positive neurons extend their neurites in control condition (upper panel). Majority of the IB4-positive
neurons do not produce any neurite when 4aPDD at low dose (0.1 mM) was applied for 36 hours (middle panel). An enlarged view of an IB4-positive
and an IB4-negative neuron is shown in the lower panel. Note that the majority of the IB4-negative neurons remain unaffected even in the presence
of 4aPDD. c. CHO-KI-TRPV4 cells that express low level of TRPV4 or CHO-KI-Mock cells that do not express TRPV4 were activated with 4aPDD (1 mM).
After activation, cells were extracted by detergent in isotonic buffer and fixed subsequently by PFA. Cells were immunostained for actin (green) and
tubulin (red). CHO-KI-TRPV4 cells loose all the peripheral microtubules but retain filamentous actin after activation and extraction. The stable MTOC
regions are marked with arrows. In contrast, CHO-KI-Mock cells remain unaffected. Intensity of the microtubule is shown (red and blue indicate
highest and lowest intensity respectively).
doi:10.1371/journal.pone.0011654.g004
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or varicosity formation (data not shown). Thus we tested if long-
term exposure to a TRPV4 agonist but a low-level activation of
TRPV4 can regulate the neurites. For that purpose, DRG neurons
were cultured for 36 hours and then treated with a low dose of
4aPDD (0.1 mM) for an additional 36 hours. Neurons were
visualized for neuron-specific bIII tubulin. Immunodetection of
TRPV4-positive neurons was not conclusive due to the very low
endogenous expression of TRPV4 in DRG neurons in this stage.
Thus, we categorized the DRG neurons by staining with IB4
lectin, which mark a subsection of nociceptive neurons [49]. We
observed that due to long-term exposure of 4aPDD, majority of
the IB4-positive neurons developed much shorter neurites if at all
(Fig. 4b). In contrast, under the same condition, IB4-negative
neurons revealed long neurites similar to non-treated neurons
(Fig. 4b). This confirmed that long-term exposure to a TRPV4
agonist resulted in growth cone and neurite retraction, and
demonstrates that this effect is restricted to a subpopulation of
nociceptors.
Activation of TRPV4 results in disassembly of
microtubules
Previously it has been shown that activation of Ca
2+ channels
causes rapid reorganization of the cytoskeleton [31,50–51]. Also,
rapid disassembly of microtubules causes growth cone retraction
[32,34,52]. So, we tested if in contrast to a stabilizing function of
TRVP4 at resting stage, activation of this channel leads to
destabilization of microtubules. To better differentiate between
soluble and polymerized cytoskeleton components, soluble pro-
teins were removed by Digitonin-extraction leaving behind only
the insoluble intact cytoskeleton. Extraction of unstimulated
TRPV4 expressing F11 cells showed fine filamentous microtubules
(Fig. S5a). But application of 4aPDD (1 mM) resulted in loss of
microtubules from the majority of TRPV4 expressing F11 cells. In
contrast, cells, which did not express TRPV4 were unaffected by
4aPDD (Fig. S5a).
We observed that the cytoskeleton rearrangement by TRPV4
was not restricted to the neuronal cells only. In TRPV4 expressing
CHO-KI cells 4aPDD treatment induced loss of almost all
microtubules whereas non-transfected cells retained all their
microtubules (Fig. S5b). Similarly, we observed loss of all
peripheral microtubules by application of 4aPDD in CHO-KI-
TRPV4 cells, which express low level of TRPV4 stably (Fig. 4c).
Under the same conditions, CHO-KI mock-transfected cells
retained all microtubules. All these results confirm that activation
of TRPV4 results in microtubules disassembly and this effect is
independent of TRPV4 expression level in whatever cellular
context chosen.
Activation of TRPV4 results in formation of elongated
filopodia
We also explored if TRPV4, being present at the filopodia can
alter the actin cytoskeletal dynamics upon activation. For that
purpose, we expressed TRPV4-GFP and actin-red in F11 cells and
monitored the filopodial structures. We observed that activation of
TRPV4 by 4aPDD results in rapid change of lamellipodia to
filopodia and/or further elongation of filopodial structures (Fig. 5).
These changes were observed at filopodial structures emanating
from the cell body as well from neurites. We observed that during
this change, several lamellipodial actin ribs fused into single
filopodial structures and TRPV4-GFP localized at the filopodial
tips (Fig. 5b). At the same time, lamellipodial region located
between two actin-ribs retract.
Stabilization of microtubules by Taxol reduces Ca
2+-influx
through TRPV4 activation
In contrast to a unidirectional effect of TRPV4 activation on
microtubule integrity, we explored if microtubule dynamics can
also affect the TRPV4 channel properties. We measured Ca
2+-
influx via TRPV4 as an indicator of TRPV4 channel opening.
We compared the Ca
2+-influx via TRPV4 in response to 4aPDD
in the presence and absence of Taxol. We observed that the
normalized average Ca
2+-influx due to TRPV4 activation was
strongly diminished (but not abolished) if the cells were treated
with Taxol (Fig. 6a). This suggests a partial inhibition of TRPV4
channel activity due to stabilization of microtubules. This
reduction due to Taxol treatment (30 min) was also observed
when cells were activated by 4aPDD for a second time (Fig. 6a).
To understand the extent of reduction, we compared the total
Ca
2+-influx (Fig. 6b). We observed 21.9% reduction in the case of
the 1
st pulse in presence of Taxol when compared to Taxol-free
control condition. However, this difference remain non-signifi-
cant at (P.0.05) (Fig. 6b). However, this difference was even
higher in the case of the 2
nd pulse where a major reduction
(61.79%) was observed in the presence of Taxol (compared with
Taxol-free 2
nd pulse condition). At the level of P,0.05, this
difference is significant. To confirm this inhibitory effect of
microtubule stabilization on TRPV4 channel opening, we
analysed by another parameter, i.e. the time each cell took to
reach its maximum response. We observed that Taxol-treatment
resulted in a delay of the cells to reach their maximum response
level (Fig. 6c). Though this time difference indicates a clear trend
of inhibition, the differences remain non-significant (Fig. 6c). By
immunofluorescence analysis (Fig. S6) and surface-biotinylation
experiments (Fig. S7), we confirmed that the presence of
microtubules and TRPV4 at the cell membrane or nearby
regions was also not altered by Taxol application. Taxol did not
alter the distribution of TRPV4 in the cell surface also. Taken
together, these results suggest that microtubule dynamics can
regulate TRPV4 channel properties.
Discussion
A substantial amount of work has been done to identify
endogenous and exogenous sensitizing stimuli, their target proteins
and elucidate their molecular effects on nociceptive neurons. Yet,
the detailed cellular and molecular mechanisms underlying
sensitization against mechanical stimuli and the specific molecular
components associated with these signaling events are not well
understood. A priori, as there is no force without counterforce,
scaffold structures like the cytoskeleton and/or the extracellular
matrix are intuitively likely to be required for stimulus detection
and execution of the responses. In nociception, so far the
cytoskeleton has been described as an important regulator of
sensitization only on a behavioural level [29,42,53–58]. In
contrast, in systems other than nociception, genetic, biochemical,
cellular as well as behavioural data are indicative of the
importance of the cytoskeleton for mechanosensation in general
[29,59–60]. Thus, contrasting the wealth of data in non-
nociceptive context, the nearly complete lack of molecular data
about an involvement of the microtubule and actin cytoskeleton in
pain sensitization is surprising. Though, recent results demon-
strated the expression of TRPV4 in Merkel cells and linked
TRPV4 function with the mechanotransduction [61,62], in the
context of nociceptive and non-nociceptive mechanosensitivity, a
direct physical interaction of actin or microtubule cytoskeleton
with ion channels has not been reported. Therefore, we now
provide the first evidence that both actin and microtubule
TRPV4 Regulates Cytoskeleton
PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11654cytoskeleton components interact directly and functionally with a
mechanosensitive ion channel, namely TRPV4.
The C-terminus of TRPV4 interacts directly with actin and
microtubule cytoskeletal components
The C-terminus of various TRP channels has been shown to be
of importance. For example, a recent study reported that the
deletion of the C-terminal cytoplasmic domain of TRPV4 strongly
inhibits membrane localization [63]. And also the C-terminus of
TRPC4 interacts with another cytoskeletal component, spectrin,
which is essential for the surface expression of the receptor [64]. In
this work we now demonstrate that TRPV4-Ct is sufficient for the
interaction with tubulin and actin as well as signaling-components.
The interaction of MBP-TRPV4-Ct to tubulin and actin appears
to be very strong as these interactions withstand the presence of
high salt concentrations (500 mM NaCl, data not shown). If the N-
terminal cytoplasmic domain of TRPV4 can also interact with the
cytoskeleton has not been established yet.
We observed that TRPV4 co-localized with actin-enriched
structures, such as focal adhesion points, filopodial and lamellipo-
dial structures. These results fit well with the previously described
subcellular localizations of TRPV4 in actin cytoskeleton-enriched
structures like dendritic spines [65]. This also accords well with the
reported presence of a2 integrin, an actin binding protein in the
TRPV4 complex [66]. We show that TRPV4 physically interacts
with soluble actin as well as with polymerised actin filaments via its
Figure 5. Activation of TRPV4 results in reorganization of actin cytoskeleton. Shown are the confocal images of live F11 cells expressing
TRPV4-GFP (green) and Actin-RFP (red). a. Activation of TRPV4 results in merging of several actin-ribs at the tips and further transition of lamellipodial
structures to filopodial structures. The arrow indicates the region and direction of the cell retraction at the same time. b. Activation of TRPV4 results
in lateral initiation of filopodial structures from neurites and further elongation of them.
doi:10.1371/journal.pone.0011654.g005
TRPV4 Regulates Cytoskeleton
PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11654C-terminal cytoplasmic domain. Thus, our biochemical study
confirms and extends a recent fluorescence resonance energy
transfer (FRET) analysis performed on live cells demonstrating
close proximity of actin and TRPV4 [67]. Interestingly, a recent
study shows that disruption of the actin cytoskeleton increases the
intracellular mobility of TRPV4-GFP and results in loss of co-
localization of TRPV4 with actin [68]. Our findings suggest that
the direct interaction of TRPV4 and actin is a general feature
observed in various cellular systems. This indicates the importance
of the interaction far beyond the nociceptive system.
Recent EM study also reveals that TRPV4 forms a ‘‘hanging
gondola’’-like structure which undergoes different structural
conformations representing open and closed state of the channel
[69]. According to this structure, the C-terminus of TRPV4 is
exposed outside and accessible for interaction with other proteins.
In that context, it is tempting to speculate that interaction of
TRPV4 with the actin and tubulin may have an importance for
such conformational changes. It is also important to note that the
presence of GFP tag (240 amino acid) at the C-terminus of
TRPV4 retains perfect co-localization of TRPV4-GFP with actin
and microtubule cytoskeleton, indicating that the tubulin-binding
region located with the TRPV4-Ct is most likely not present at the
extreme C-terminal free end of the TRPV4. Previously, we
identified two novel tubulin-binding motifs, which we mapped to
the C-terminal cytoplasmic domain of TRPV1 [36–37]. They
consist of two short basic amino acid-rich sequence stretches,
which are thought to interact directly with the acidic overhangs of
tubulin. Indeed, positively charged amino acids in one of these two
novel motifs are partially conserved in the C-termini of TRPV4
and TRPV2 [37]. Though we did not perform deletion mapping,
based on other experimental evidences and best of our
understanding, we applied a similar conceptual basis and
predicted that the basic amino acid residues present within the
C-terminus of TRPV4, especially within the 746 to 779 amino
acids may interact with tubulin (Fig. S1). Though the ability of this
small region to interact with tubulin needs to be experimentally
verified, we found that indeed the total C-terminus of TRPV4
interacts with tubulin and/or microtubules. Thus, beyond the
reported indirect binding through MAP7 [70], we find direct
interaction of TRPV4 to microtubule cytoskeleton. In this study
we have not tested if the N-terminal region of TRPV4 can
interacts with actin and tubulin. However, considering the fact
that the N-terminus of TRPV4 contains multiple ankyrin repeats
which are presumably important for protein interaction possible
interaction of tubulin and actin at the N-terminus cannot be ruled
out completely. In this context, it is worth mentioning that recent
studies demonstrate that point mutations located at these ankyrin
repeats at the N-terminus either increase or decrease the TRPV4
activity and results in genetic disorders [71–73].
In this work we investigated if TRPV4 can affect microtubule
properties. Binding of different post-translationally modified
tubulins suggests that TRPV4 can modulate the stability of the
microtubules. Indeed, we show that TRPV4 stabilizes microtu-
bules at the membrane. These microtubules at the membrane can
Figure 6. Microtubule cytoskeleton regulates Ca
2+-influx via TRPV4. a. Taxol (1 mM, 30 minutes) reduces TRPV4-mediated Ca
2+-influx in
Cos7 cells. Shown are the normalized average ratiometric Ca
2+-influx in arbitrary units (AU). TRPV4 was activated by a pulse (indicated by a black line)
of 4aPDD for 10 sec. The dark blue line (C1) represents average response due to first pulse in control conditions (n=32), the light blue line (C2)
represents average response due to second pulse in control conditions (n=32), the blackish green line (T1) represents average response due to first
pulse under the influence of Taxol-stabilized microtubules (n=42) and the light green line (T2) represents the average response due to second pulse
under the Taxol-stabilized microtubules (n=30). b. Cells with Taxol-stabilized microtubules reveal reductions in total Ca
2+-influx due to TRPV4
activation. Total Ca
2+-influx was calculated from the total area appeared by the ratiometric calcium-influx graph (as shown in figure a) for each cell
and was calculated by Origin 7G software. At the ,0.05 level, the difference of the population means between 2
nd pulse (untreated and taxol-treated,
one sample t-test) is significant (*). The difference in case of 1
st pulse is non-significant. c. Taxol stabilized cells reveal a trend for time delay to reach in
maximum response. The time (in seconds) each cell took to reach its maximum response (indicated by filled triangles) was plotted. Times needed
during first pulse in control conditions (dark blue), second pulse in control conditions (light blue), first pulse with Taxol (blackish green) and second
pulse with Taxol (light green) are indicated. The average values (indicated by filled squares) and the standard deviations are also shown for each
condition. The average time differences remain non-significant.
doi:10.1371/journal.pone.0011654.g006
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tubulin’’, indicating that these microtubules are dynamic in nature
[74–75]. How TRPV4 stabilizes microtubules in vivo is not clear.
But our in vitro work indicates that the C-terminus of TRPV4 is
sufficient for microtubule stabilization. The extent of microtubule
stabilization by TRPV4-Ct is apparently very strong as TRPV4-Ct
stabilizes microtubules are resistant against potent microtubule
destabilizers such as Nocodazole and Ca
2+. Thus, TRPV4-Ct
induces ‘‘Nocodazole-resistant microtubules’’, a class of microtu-
bules that has very different physico-chemical properties [76–77].
Notably, a fraction of ‘‘Nocodazole-resistant microtubules’’ are
known to be resistant against Ca
2+ and cold-induced depolymer-
ization [78–79]. The resistance of a subset of microtubules against
calcium is of high importance at the base of an ion channel, which
among others allows calcium influx if activated. The observed
binding of post-translationally modified tubulin such as acetylated
tubulin, detyrosinated tubulin and polyglutamylated tubulin to
TRPV4 may also explain the stabilization as these tubulins are
known to be involved in the formation of stable microtubules
[76,80–81].
Regulation of growth cone, neurites and filopodia by
TRPV4
Cellular and neuritic morphology is modulated through
mutual regulation of the actin and microtubule cytoskeleton.
The microtubule cytoskeleton provides an anterograde force
while the actin cytoskeleton provides retrograde force. Thus these
two opposing forces regulate the morphology and determine the
net movement of neurites [32–34,52,82]. As TRPV4 modulates
actin as well as microtubule stability, it has the ability to steer
growth cone movements. This result matches well with our
previous work demonstrating that activation of TRPV1 causes
rapid disassembly of microtubules and thus regulates growth cone
movement [31–32,51,82]. However, unlike TRPV1, TRPV4
activation-mediated (by using 4aPDD) disassembly of microtu-
bules in DRG neurons, in transfected F11 cells as well as in
non-neuronal cells seems to be much slower. Therefore, TRPV1
and TRPV4 might be involved in regulation of the neuronal
architecture not only in response to different stimuli but also
along a different timescale.
Regulation of TRPV4 activity by actin and microtubule
cytoskeleton
TRPV4 not only changes the cellular cytoskeleton but the
cellular cytoskeleton is in turn also altering the TRPV4 channel
properties. On one hand TRPV4 regulates stability-instability of
the microtubules and reorganizes them, on the other hand
microtubule dynamics regulate the Ca
2+-influx through TRPV4.
We now show that stabilization of microtubules by Taxol in vivo
results in reduction and delay in TRPV4-mediated Ca
2+-influx.
Though the values are not statistically significant, these differences
show a clear trend of Taxol-mediated inhibition of TRPV4. This
result accords well with the fact that Taxol reduces TRPV4-
mediated currents in transfected CHO cells [70]. Along the same
line, evidence suggests that the actin cytoskeleton can also regulate
the TRPV4 channel activity as disruption of the actin cytoskeleton
impairs the TRPV4-mediated currents [70] and Ca
2+-influx in
TRPV4 expressing cells in response to hypotonic shock [68].
However, the molecular mechanism underlying this inhibitory
effect of Taxol on TRPV4-mediated Ca
2+-influx is not yet clear.
Unlike the response to microtubule destabilizers (like Nocodazole),
the integrity of microtubule cytoskeleton, microtubule-based
transport and membrane distribution of TRPV4 are not compro-
mised by this short-term Taxol application. We predict that this
modulation is most likely due to the conformational change of the
channel complex induced by the dynamic presence or absence of
the microtubule cytoskeleton and its associated components, which
correlates with either channel closure and/or desensitisation. In
agreement with this concept, it is important to note that activation
of single TRPV4 ion channel in responseto heat is possible in whole
cell recordings but not in a cell-free inside-out patch clamp
experiments, suggesting that in the latter some cellular factor is
missing [83]. In this regard it is tempting to speculate an
involvement of microtubules there. While in the course of the
excision still some microtubules might be attached to the TRPV4
complex, later on it might disassemble easily as filamentous
microtubules are sensitive to dilution [84]. However, further single
channel electrophysiological investigations are required.
TRPV4 and cytoskeleton in the context of intracellular
pain signaling
Previously it has been shown that potentiation, spontaneous
activity and desensitisation of TRPV4 are Ca
2+-dependent
processes, suggesting Ca
2+-dependent signalling occurs [44,85–86].
Indeed, TRPV4 interacts with calmodulin in a Ca
2+-dependent
manner [44]. In agreement with that, we also observed the
presence of CamKII in the complex formed by TRPV4-Ct, but
only in the presence of Ca
2+ (Fig. 1c). This is in line with a
reported role of CamKII in pain [46]. It also indicates that
CamKII may regulate TRPV4 function. However, not all
signalling molecules associate with TRPV4 in a Ca
2+-dependent
manner. PKCe,aC a
2+-independent kinase investigated in
various aspects of mechanical sensitization [39–42,87–88]
interacts with the C-terminus of TRPV4 in the presence as well
as absence of Ca
2+. Our results are also in line with a recent
report demonstrating that TRPV4 phosphorylation at its N-
terminus is important for its activation and PKCs along with
PKA are important for this phosphorylation [45]. The same
report demonstrates that PKCs form a complex with the TRPV4
in the presence of AKAP proteins which function as scaffolds.
Considering the fact that AKAP proteins interact with tubulin
[89], our results suggest that the complex we identified has a
mechanistic function. Though, direct phosphorylation of the C-
terminus of TRPV4 by PKCe in vitro has not been shown so far,
but PKC-mediated potentiation of TRPV4 has been observed
[1,43] and PKCe-dependent activation of TRPV4 has been
described in vivo [90]. In our preliminary in vitro experiments too,
we failed to observe any phosphorylation mediated by recombi-
nant (and purified) PKCe when purified MBP-TRPV4-Ct was
used as a substrate (data not shown). However, a recent study has
demonstrated that in vivo condition, S824 position of the TRPV4
is phosphorylated by PKC [91]. However, this phosphorylation
might be mediated by other PKC isotypes and may not be by
PKCe. Based on our results and data from others, we believe that
PKCe most likely sequesters at the C-terminus of the TRPV4 in
order to phosphorylate the N-terminus and/or it needs other
factors. Nevertheless the complex we isolated in this work appears
to be of importance, as cytoskeletal components, CamKII, PKCe
and TRPV4; all are known to be involved in pain sensitization
[46,58,90].
TRPV4 and microtubule cytoskeleton also share similarities in
terms of regulation by Sac tyrosine kinase, a pro-nociceptive
regulator at the plasma membrane. On a cellular level, Src
tyrosine kinase activity in response to mechanical force is localized
mainly at the membrane [53]. In accordance with that, Src
tyrosine kinase phosphorylates membrane-associated tubulin of
neuronal origin [92]. This kinase activity is important for TRPV4
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membrane-associated tubulin-TRPV4 complex seems to be
important for stimuli that activate Src-tyrosine kinase.
Microtubules and TRPV4 in pain sensitization
Involvement of cytoskeleton in pain sensitisation has been
anticipated for a long time, as microtubule-based chemothera-
peutics against cancer are known to induce severe long-lasting
neuropathic pain [94]. But, how these chemotherapeutics, like
Taxol and Vincristine alter pain sensitivity is not well understood.
Microtubules and mitochondrial structures develop abnormalities
in nociceptive neurons due to prolonged and systemic application
of these chemotherapeutics [95–97]. Even stabilization of
microtubules by short-term application of Taxol (30 min) exerts
an impact on pain sensitization [58]. It is important to mention
that disruption of microtubules by short-term (30 min) application
of Nocodazole abolishes/reduces pain sensitization [58]. These
suggest that the integrity of microtubules can indeed modulate
pain sensitivity [98]. TRPV4 has recently been considered as
essential for chemotherapy-induced neuropathic pain as mechan-
ical hyperalgesia induced by Taxol and Vincristine was strongly
reduced in trpv4 2/2 mice [30,66].
We established a direct physical, cell-biological and functional
relationship between cytoskeletal components and TRPV4, which
plays an important role in inflammatory, neuropathic and
chemotherapeutic-induced pain [30,58,66]. This gives a mecha-
nistic base to further study the role of the apparent dynamic
signalling complex formed by TRPV4 and its functional
implications in various physiological scenarios.
Materials and Methods
Reagents and antibodies
Taxol, Nocodazole, 4aPDD, bovine actin, tetramethylrhodamine
isothiocyanate-labelled IB4 from Griffonia simplicifolia, antibodies
against a-tubulin (clone DM1A), b-tubulin (clone D66), tyrosinated
tubulin (clone TUB1A2), polyglutamylated tubulin (clone B3),
acetylated tubulin (clone 611-B-1), phospho-serine (Clone PSR-45),
b-tubulin sub type III (clone SDL.3D10), neurofilament 116 kDa
(clone NN18) and the affinity purified rabbit polyclonal antibody
against C-terminal cytoplasmic domain of TRPV4 were purchased
from Sigma-Aldrich (Taufkirchen, Germany). Antibodies against
neurofilament 200 kDa (clone RT97) and detyrosinated tubulin were
purchased from Chemicon (Chandlers Ford, UK). The antibody
against actin (clone JLA20) was purchased from Oncogene (Cam-
bridge, MA, USA). Antibody against maltose-binding protein (MBP)
and the amylose resin were purchased from New England Biolab
(Beverly, MD, USA). Purified bovine muscle actin was purchased
from Sigma-Aldrich (Taufkirchen, Germany). Protein G-agarose was
purchased from Amersham Pharmacia Biotech (Munich, Germany).
For some experiments, another affinity purified rabbit polyclonal
antibody raised against TRPV4 (kind gift from Jon D. Levine) was
used [3]. Anti CamKII antibody was purchased from BD
(Heidelberg, Germany). Anti PKCe antibody (KP4) was a kind gift
from Dr Robert Messing, University of California San Francisco. All
secondary IgG antibodies (alexa-488-labelled anti-mouse, alexa-488-
labelled anti-rabbit, alexa-594-labelled anti-rabbit, alexa-594-labelled
anti-rat, Fura-2/AM, alexa-488- and alexa-594-labelled Phalloitoxin
were purchased from Invitrogen (Karlsruhe, Germany).
Constructs
Full-length TRPV4 (NCBI accession number AF263521) in
pCDNA3.1 vector was a kind gift from Prof. Jon D Levine [3]. For
expression of C-terminal cytoplasmic domain (amino acid residue
718 to 871) of TRPV4-fused with MBP, the corresponding cDNA
region of TRPV4 (NCBI accession number AF263521) was
amplified by using forward primer (59TGACGAATTCATG-
GGTGAGACCGTGGGCCA39) and reverse primer (59TGA-
CAAGCTTCTACAGTGGTGCGTCCTCCG39). The ampli-
fied cDNA was sub cloned into the EcoRI and HindIII restriction
site of the pMALc2x vector (NEB, Beverly, MD, USA) and
verified by automated nucleotide sequencing. TRPV4-GFP
construct (cloned in pEGFPN3 vector) used in this study was
kindly provided by Prof. J. Berreiter-Hahn [10]. Tubulin-cherry
construct was a kind gift from Prof. R. Y. Tsien [99]. RFP-actin
construct was purchased from Clontech (Heidelberg, Germany).
Cells and transfection
F11 cells [38] were cultured in Ham’s F12 medium (Sigma
Aldrich) supplemented with 20% fetal bovine serum (Sigma
Aldrich). Cos7 [100] and HaCat [101] cells were maintained in
Dulbecco’s modified Eagle’s medium (Sigma Aldrich) with 10%
fetal calf serum. CHO-K1 cells [3] stably transfected with TRPV4
(CHO-K1-TRPV4) and the negative control cell line (CHO-K1-
MOCK) [3] was cultured in F12 Ham’s (Sigma Aldrich) medium
supplemented with 5% fetal bovine serum (FBS) and L-glutamine.
These two cell lines were kindly provided by Prof. J. D. Levine [3].
All media were supplemented with streptomycin (100 mg/ml) and
penicillin (100 mg/ml) (Invitrogen). Cells were maintained in a
humidified atmosphere at 5% CO2 and 37uC. For transient
transfection, Lipofectamine (Invitrogen) was used according to the
manufacturer’s instructions.
Ethics Statement
Cell biological experiments were performed in cultured DRG
neurons from male Sprague-Dawley rats (200–300 g; Harlan
Winkelmann, Borchen, Germany). Care and use of animals were
in accordance with the European Communities Council Directive
of 24 November 1986 (86/609/EEC) and were approved by the
LaGeSo, Berlin. All efforts were made to minimize the number of
animals used and their suffering.
DRG neuronal culture and neurite out growth
Dissociated rat DRG neurones were prepared from adult male
rats (200–300 g) as recently described [32]. Neurons were grown
in 24-well plates at 37uCi n5 %C O 2 and were grown for a total of
72 h. At that time most untreated neurons grow numerous and
long neurites. In some experiments neurons were treated with
4aPDD (0.1 mM for the last 36 hour) before they were fixed with
2% PFA. Subsequently the neurons were visualized for bIII-
tubulin (antibody dilution 1:1000) and IB4-lectin (1:15000).
Immunoprecipitation
For immunoprecipitation, approximately 50 ml of 50% protein
G beads-slurry equilibrated with IP buffer (1% sodium dodecyl
maltoside, PIPES 50 mM (pH 6.8), 100 mM NaCl, 1 mM EGTA,
0.2 mM MgCl2 and complete protease inhibitors (Roche) was used
for each IP. Affinity purified rabbit polyclonal TRPV4 antibody
(Sigma Aldrich) (7 mg per IP condition, antibody obtained from
Sigma-Aldrich) was used. In control, total serum IgG from rabbit
(7 ml which is equivalent to 20 mg of antibody) was used as non-
specific antibody. For co-immunoprecipitation, CHO-KI-TRPV4
cells grown for 2 days and then scraped off from the dishes. Cells
were harvested by centrifuging (Hettich Rotanta/T, 5 min at
100 g). Cells were washed with PBS once and centrifuged again at
the same conditions. Cells were resuspended in 2 ml of IP buffer
and homogenized (10 strokes) with a glass-Teflon homogenizer
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16 K (25000 g) for 30 minute at 4uC and the clear supernatant
was used for IP. Similarly, DRG tissues (L1-L6) from 2 male rats
were isolated, homogenized in IP buffer. The lysate was
centrifuged at 25.000 g, 30 min at 4uC and the clear extract was
used for the further IP. Clear cell extract (800 ml equivalent to
1 mg of protein) and the corresponding antibody were applied to
the equilibrated protein G beads. The mixture was incubated at
25uC for 4 hours on a shaker. After that the beads were washed 3
times, each time with 400 ml of IP buffer. A Hamilton syringe was
used for all washing steps. Finally the beads were taken in 100 mlo f
IP buffer and 50 ml of 5x Laemmli sample buffer was added. The
samples were boiled and used for western blot analysis.
Expression and purification of MBP-fusion proteins
Expression and purification of MBP-TRPV4-Ct (C-terminal
cytoplasmic domain of TRPV4 fused with MBP) as well as of
MBP-LacZ (LacZ fused with MBP) was based on a protocol
described previously [36]. In short, the expression constructs were
introduced into the Escherichia coli (E. coli) strain BL21DE3 by
transformation heat shock method. Fusion protein expression was
induced by addition of isopropyl thiogalactoside (IPTG) for 2 h.
Cells were lysed by repeated freeze-thaw cycles in lysis buffer
(20 mM Tris–HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 20,
lysozyme, benzonase and protease inhibitor cocktail). The lysed
extracts were cleared by centrifugation (100000 g in a TFT 45
rotor for 2 h) and applied to amylose resin. The resins with bound
proteins were washed thoroughly and finally the proteins were
eluted with 10 mm maltose in elution buffer (50 mM PIPES,
pH 6.8, 100 mM NaCl, 1 mM EGTA and 0.2 mM MgCl2).
Pull down assays
MBP-LacZ and MBP-TRPV4-Ct constructs were expressed in
E. coli; the cleared cell lysates were applied to amylose resin (NEB),
and incubated for 1 hour at RT (25uC) followed by washing. The
amylose resin with bound proteins was resuspended in PEM-S
buffer (50 mM PIPES, pH 6.8, 100 mM NaCl, 1 mM EGTA and
0.2 mM MgCl2). Approximately 50 ml of amylose resin per tube
with the bound fusion protein was used for pull-down experiments.
Depending on the respective experiment, the resin with coupled
fusion protein was incubated with either 50 ml of soluble tubulin
(1 mg/ml protein), 20 ml of soluble actin (0.1 mg/ml), 500 mlo f
soluble brain extract (1 mg/ml), or 500 ml of soluble F11 extract
(1 mg/ml) for 1 hour at RT in the presence or absence of Ca
2+
(2 mM). This was followed by three washes with 200 ml PEM-S
buffer. The proteins were eluted by 10 mm maltose in 100 ml
solution. Eluted samples were analysed by 10% sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS–PAGE).
Co-sedimentation assay with polymerised actin, Taxol-
stabilized microtubules (MT) and analysis for microtubule
stability
For experiments aimed at understanding the association of
TRPV4-Ct with polymerised actin filaments, purified MBP-
TRPV4-Ct alone was subjected to centrifugation at 70000 g/
30 min/4uC to exclude any aggregates. The soluble MBP-
TRPV4-Ct was further processed for all co-sedimentation assays.
Either 5 mg of purified MBP-TRPV4-Ct or MBP alone in total
50 ml of PEM-S buffer or only 50 ml of PEM-S buffer was added
to a saturated actin solution (50 mg actin in total 50 ml) in
centrifuge tubes. ATP at a final concentration of 2.5 mM was
added to each tube. The reaction tubes were incubated at 37uC
for 30 minutes followed by centrifugal separation of pellet
(polymerised actin filaments) and supernatant (free dimer) at
70000 g/30 min/37uC.
Approximately 100 mg of purified ab-tubulin dimer in a total
volume of 100 mL were incubated in modified PEM buffer
(20 mm PIPES, pH 6.8, 0.2 mm MgCl2 and 1 mm EGTA
supplemented by 1 mm Taxol and 5 mm GTP) for 30 min at
37uC, to form MTs. After that the MT were isolated by
centrifugation at 70 000 g/30 min/37uC. Purified MBP-TRPV4-
Ct or MBP only (each 5 mg) were incubated with Taxol-stabilized
MT for 40 min at 37uC followed by centrifugal separation of pellet
(MT) and supernatant (free dimer) at 70 000 g/30 min/37uC.
In another experiment, MT was formed under Taxol-free
conditions. Tubulin dimer (100 mg) with purified MBP-TRPV4-Ct
or MBP only (5 mg each) were taken in total 100 ml PEM-S buffer
with 5 mm GTP in the absence of Taxol and incubated for
30 min at 37uC. After that the MT and bound proteins were
separated by centrifugal separation of pellet (MT) and supernatant
(free dimer) at 70000 g/30 min/37uC.
For experiments aimed at understanding the effect of TRPV4-
Ct on MT stabilization, either 5 mg of purified MBP-TRPV4-Ct
or MBP alone in total 50 ml of PEM-S buffer or only 50 mlo f
PEM-S buffer was added to a tubulin solution (5 mg tubulin in
total 50 ml) in centrifuge tubes. Depending on the experimental
conditions, MT-depolymerizing agent Nocodazole (final concen-
tration 10 mM), Ca
2+ (final concentration 0.1 mM) or both
Nocodazole and Ca
2+ was added to the tubes. GTP at a final
concentration of 2.5 mM was added to each tube. The reaction
tubes were incubated at 37uC for 30 minute s followed by
centrifugal separation of pellet (MT) and supernatant (free dimer)
at 70000 g/30 min/37uC.
Purification of tubulin
ab-tubulin dimers were purified from porcine brain as described
previously [36]. In brief, from soluble brain extract tubulin was
enriched by two cycles of polymerization in the presence of
glycerol and GTP and depolymerization by cold temperature (ice
cold), which were then followed by chromatography on phospho-
cellulose.
Immunocytochemistry
For immunocytochemical analysis, cells were washed once with
PBS and fixed with 2% PFA/PBS if not mentioned otherwise.
Alternatively, where mentioned, an equal volume of 4% PFA was
carefully added to the medium without disturbing the cell culture
within the incubator to avoid morphological changes due to the
PBS wash. The cells were fixed with PFA for 5 minutes at room
temperature (25uC). For experiments aimed to explore the
integrity of the cytoskeleton after TRPV4 activation, soluble
components were removed by digitonin extraction as described
before [31]. Briefly, after activation the cells were extracted with
an isotonic cell membrane-permeabilization buffer (digitonin
(50 mg/ml), PIPES (50 mM pH 6.8), EGTA (1 mM), MgCl2
(0.2 mM) and complete protease inhibitors (Roche) that perforates
the cell membrane and allow all the soluble cellular proteins to
diffuse out while insoluble cytoskeleton and cell morphology
remain intact. After extraction the cells were quickly fixed with 2%
PFA. Fixed cells were permeabilized with 0.1% Triton X-100 in
PBS (5 min) and subsequently blocked with 5% normal goat
serum or 5% BSA.
For co-immunostaining of TRPV4 and tubulin, a rabbit
polyclonal anti TRPV4 antibody (Sigma Aldrich) and a rat
monoclonal anti-tyrosinated tubulin antibody (clone YL1/2) were
used. For staining of actin filaments, either alexa-594 or alexa-488
labelled Phalloidin (molecular probe) was used. Alexa 594-labelled
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were used as secondary antibodies. For labeling IB4-positive
neurons, tetramethylrhodamine isothiocyanate-labelled IB4 from
Griffonia simplicifolia was used at 1:15000 dilutions in PBST
supplemented with 0.2 mM CaCl2, 0.2 mM MgCl2 and 0.2 mM
MnCl2 and incubated for 30 minutes. All images were taken on a
confocal laser-scanning microscope (Zeiss Axiovert 100 M) with a
63x-objective and analyzed with the Zeiss LSM image examiner
software.
TRPV4 activation and live cell imaging
For visualizing the effect of TRPV4 activation, F11 cells were
seeded on glass cover slips. Two days after transfection with
TRPV4, the cells in either complete medium or in HBSS buffer
were imaged at RT. Where indicated, TRPV4-GFP was co-
expressed with either RFP-Actin or Tubulin-cherry. In experi-
ments aiming to activated TRPV4, its agonist 4 a-phorbol 12,13-
didecanoate (4aPDD) was used at a final concentration of 1 mm, if
not stated otherwise [22].
Calcium imaging
For measuring the TRPV4 channel activity; Ca
2+-imaging was
performed using Cos7 cells at room temperature (25uC). Cos7 cells
plated on glass cover slips and transiently transfected with TRPV4
and a yellow fluorescent protein (YFP) reporter plasmid. Cells
transfected with only YFP reporter plasmid were used as controls.
The transfected cells were used for the experiments at around
48 hour later transfection. Cells were loaded with 3 mM Fura-2
AM and placed in a recording chamber that allowed direct
application of buffer at controlled temperature (27 to 30uC).
Loading of Fura-2 AM dye and the fluorescence measurements
were done in calcium imaging buffer (140 mM NaCl, 4 mM KCl,
2 mM CaCl2, 1 mM MgCl2, 5 mM Glucose, 10 mM HEPES,
pH 7.4). Cells were activated by 4aPDD (1 mM) for 10 seconds
after first 30 seconds of imaging. Images were captured in every 2
seconds for a total of 3 minutes. 10 minutes after the 1
st round of
activation (1
st pulse of 4aPDD) and imaging, cells on the same
cover slips were imaged again for the next round (2
nd pulse of
4aPDD). In experiments aimed to analyze the effect of
microtubule stabilization, Taxol (1 mM) was maintained through-
out the experiment in all solutions used, i.e. during the dye
loading, during activation by 4aPDD and in between when
running calcium-imaging buffer was applied. Ratiometric calcium
imaging was performed and analyzed using Tillvision software
(Till Photonics, Germany). Fluorescence was measured at
excitation wavelengths alternating between 340 nm and 380 nm.
Following subtraction of background fluorescence the ratio of
fluorescence at 340 nm and 380 nm was calculated. For
determination of total Ca
2+-influx, we measured the total area of
the graph each cell formed after stimulation. Microsoft Excel and
Origin software were used to calculate and plot the graphs. All
significance tests were performed at the ,0.05 level (one sample t-
test).
Supporting Information
Figure S1 Prediction of tubulin-binding region located within
the C-terminus of TRPV4. a. Identification of amino acid
stretches located within the TRPV4-Ct with high isoelectric point
(pI) values. The C-terminal overhanging region of tubulin contains
highly acidic residues and most of the tubulin-binding proteins
contain amino acid stretches which have high pI due to the
presence of basic residues. Therefore, the C-terminus of TRPV4
(amino acid residues 718 to 871) was analyzed for its isoelectric
points. Similarly, different fragments of TRPV4-Ct, each shorter
by 10 amino acids from the extreme C-terminal end were also
analyzed. This analysis indicates that there are two areas which
contain positively charged residues (indicated by shaded area). The
corresponding pI of each fragment is mentioned in the right most
side. In below, the secondary structure prediction is provided (red
indicates helical structure, green arrow indicates beta strand and
black line indicates unstructured coil region. Note that the arrows
do not indicate the directionality of the strands). All theoretical pI
values of the fragments were calculated by using available software
(http://www.expasy.org/tools/pi_tool.html). All secondary struc-
ture prediction was done by using Advanced Protein Secondary
Structure Prediction Server available at http://imtech.res.in/
raghava/apssp/. b. Amino acid residues 746 to 779 contain
multiple positively charged amino acids which can potentially
form an alpha-helix. The PyMol programme was used to build this
peptide structure. Blue and red colours indicate the positive and
negative charges at the surface respectively. Notably all the
positively charged amino acids (indicated by arrows) are located in
one side of the helix and can be important for interaction with the
tubulin/microtubule (which contain negative charges at the
surface). c. These predicted and important basic charges (indicated
by blue) are conserved throughout the evolution. The NCBI
accession numbers are indicated. TRPV4, Homo sapiens (NP_
067638.3); TRPV4, Canis lupus familiaris (XP_543434.2); TRPV4,
Bostaurus (XP_001253150.1);TRPV4,Mus musculus(NP_071300.1);
TRPV4, Rattus norvegicus (NP_076460.1); TRPV4, Gallus gallus
(NP_990023.1); TRPV4, Danio rerio (NP_001036195.1); Putative
uncharacterized protein, Ailuropoda melanoleuca (PANDA_020862);
Putative uncharacterized protein, Ailuropoda melanoleuca (PAN-
DA_018294), Chromosome 12 SCAF14999, Tetraodon nigroviridis
(GSTENG00029525001).
Found at: doi:10.1371/journal.pone.0011654.s001 (7.95 MB TIF)
Figure S2 TRPV4 pulls down cytoskeletal components and
nociceptive regulator kinases from F11 cell extract. MBP-TRPV4-
Ct (lane 2–3) but not MBP-LacZ (lane 4–5) forms specific complex
when incubated with soluble F11 extract (lane 1), both in presence
(lane 2 and 4) or absence (lane 3 and 5) of Ca
2+ (1 mM). Presence
of actin, tubulin and PKCe are observed only in lane 2 and 3
whereas CamKII is present only in lane 2.
Found at: doi:10.1371/journal.pone.0011654.s002 (8.31 MB TIF)
Figure S3 TRPV4 co-localizes with actin cytoskeleton. Shown
are the confocal images of neuronal and non-neuronal cells
expressing TRPV4. Cells were stained for TRPV4 (green) and
actin (red). Presences of TRPV4 specifically in actin-enriched
structures (indicated by arrows) are shown. Enlarged views of
filopodial structures developed from HaCat cell (upper panel) and
F11 (lower panel) cell are shown.
Found at: doi:10.1371/journal.pone.0011654.s003 (0.92 MB TIF)
Figure S4 TRPV4 activation can influence the neuritic
morphology. Shown are the time-series confocal images of a
neurite developed from a F11 cell expressing TRPV4-GFP (green)
and Tubulin-cherry (red). This neurite produces varicosities
(indicated by arrows) after adding 4aPDD due to disassembly of
MT. Note that all the varicosities are formed simultaneously (at
5th minute in this case), indicating a global disassembly of
microtubules all over this neurite. Tubulin Cherry construct was a
kind gift from Prof. R. Y. Tsien (Shaner et al. 2004).
Found at: doi:10.1371/journal.pone.0011654.s004 (0.85 MB TIF)
Figure S5 Activation of TRPV4 results in microtubule disas-
sembly. a. F11 cells were mock activated with buffer or activated
with 4aPDD (1 mM) followed by detergent extraction with isotonic
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and tubulin (red). In absence of activation, TRPV4 expressing cells
retains all the microtubules (upper panel, i-iii), but lost all the distal
microtubules if activated with 4aPDD (middle panel, iv-vi). The
stable MTOC region is marked with an arrow. Note that non-
transfected cells retain all the microtubules even after addition of
4aPDD (lower panel). b. CHO-KI cells expressing TRPV4 (green)
were activated with 4aPDD (1 mM) and were further extracted
with detergent in isotonic buffer and fixed. Under this condition,
nontransfected cells show microtubules all over the cells, while
transfected cells contain very little microtubules.
Found at: doi:10.1371/journal.pone.0011654.s005 (1.67 MB TIF)
Figure S6 TRPV4 localization at membrane is not affected by
Taxol. Shown are the confocal images depicting the distribution
and co-localization of TRPV4 (green) and tubulin (red) in Cos7
cells. Cells expressing TRPV4 were fixed under control condition
(i), fixed after incubation with Taxol for 30 minute (ii) or
incubation with Nocodazole for 30 minutes (iii). Cells were
immunostained for TRPV4 (green) and tubulin (red). The white
line indicates the periphery of the cell. All these images were
acquired at an identical laser power and gain value.
Found at: doi:10.1371/journal.pone.0011654.s006 (1.62 MB TIF)
Figure S7 Microtubule stabilization by Taxol does not alter the
surface distribution of TRPV4. To confirm that Taxol-treated cells
still contain TRPV4 at the cell surface, we performed surface
biotinylation of TRPV4-GFP expressing Cos7 cells that were
either treated with Taxol (1 mM, 30 minutes) or left untreated. We
isolated TRPV4-GFP by immunoprecipitation and found that
TRPV4-GFP is similarly labelled with biotin in both conditions.
These results confirm that short-term Taxol application does not
alter the distribution of TRPV4 in the membrane. Total cell
extract in control condition (lane 1) or under Taxol-stabilized
condition (lane 2), TRPV4 immunoprecipitates from control
condition (lane 3) or from Taxol-stabilized condition (lane 4) were
blotted with TRPV4 antibody (upper panel) and with HRP-Avidin
(lower panel). Arrow indicates the position of biotinylated TRPV4.
Found at: doi:10.1371/journal.pone.0011654.s007 (1.19 MB TIF)
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